Variant report
Variant | nsv1066922 |
---|---|
Chromosome Location | chr17:19494805-19515049 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:122)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:7)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BATF | chr17:19506576-19506746 | GM12878 | blood: | n/a | n/a |
2 | BATF | chr17:19506568-19506797 | GM12878 | blood: | n/a | n/a |
3 | BCL11A | chr17:19506515-19506806 | GM12878 | blood: | n/a | n/a |
4 | BCL11A | chr17:19504533-19504714 | GM12878 | blood: | n/a | n/a |
5 | BCL11A | chr17:19506584-19506802 | GM12878 | blood: | n/a | n/a |
6 | BCL11A | chr17:19504501-19504714 | GM12878 | blood: | n/a | n/a |
7 | BHLHE40 | chr17:19502537-19502725 | HepG2 | liver: | n/a | n/a |
8 | BHLHE40 | chr17:19505000-19505221 | HepG2 | liver: | n/a | n/a |
9 | BHLHE40 | chr17:19504466-19504716 | HepG2 | liver: | n/a | n/a |
10 | BHLHE40 | chr17:19506564-19506851 | HepG2 | liver: | n/a | n/a |
11 | CEBPB | chr17:19510067-19510327 | IMR90 | lung: | n/a | n/a |
12 | CEBPB | chr17:19510104-19510313 | A549 | lung: | n/a | n/a |
13 | CEBPD | chr17:19506583-19506765 | K562 | blood: | n/a | n/a |
14 | CTCF | chr17:19509700-19509739 | Kidney_OC | kidney: | n/a | n/a |
15 | EBF1 | chr17:19506484-19506732 | GM12878 | blood: | n/a | n/a |
16 | EBF1 | chr17:19504563-19504697 | GM12878 | blood: | n/a | n/a |
17 | EGR1 | chr17:19508829-19509053 | K562 | blood: | n/a | n/a |
18 | EP300 | chr17:19506590-19506723 | GM12878 | blood: | n/a | n/a |
19 | EP300 | chr17:19504538-19504718 | GM12878 | blood: | n/a | chr17:19504679-19504693 chr17:19504678-19504692 |
20 | EP300 | chr17:19506562-19506865 | GM12878 | blood: | n/a | n/a |
21 | FOSL2 | chr17:19506540-19506776 | HepG2 | liver: | n/a | n/a |
22 | FOSL2 | chr17:19506559-19506777 | HepG2 | liver: | n/a | n/a |
23 | FOSL2 | chr17:19504456-19504740 | HepG2 | liver: | n/a | chr17:19504555-19504566 |
24 | FOXA1 | chr17:19506488-19506766 | HepG2 | liver: | n/a | n/a |
25 | GABPA | chr17:19506457-19506740 | Hela-S3 | cervix: | n/a | n/a |
26 | GABPA | chr17:19504555-19504724 | Hela-S3 | cervix: | n/a | n/a |
27 | GABPA | chr17:19506604-19506738 | Hela-S3 | cervix: | n/a | n/a |
28 | GABPA | chr17:19504585-19504675 | Hela-S3 | cervix: | n/a | n/a |
29 | GATA2 | chr17:19504512-19504716 | K562 | blood: | n/a | n/a |
30 | GATA2 | chr17:19506429-19506757 | K562 | blood: | n/a | n/a |
31 | GATA3 | chr17:19502492-19502898 | T-47D | breast: | n/a | n/a |
32 | GTF2F1 | chr17:19497442-19497453 | H1-hESC | embryonic stem cell: | n/a | n/a |
33 | HEY1 | chr17:19506598-19506777 | HepG2 | liver: | n/a | n/a |
34 | HEY1 | chr17:19506568-19506746 | K562 | blood: | n/a | n/a |
35 | HEY1 | chr17:19506440-19506752 | HepG2 | liver: | n/a | n/a |
36 | HEY1 | chr17:19504580-19504682 | HepG2 | liver: | n/a | n/a |
37 | HEY1 | chr17:19504543-19504718 | HepG2 | liver: | n/a | n/a |
38 | IRF4 | chr17:19506540-19506776 | GM12878 | blood: | n/a | n/a |
39 | IRF4 | chr17:19506493-19506768 | GM12878 | blood: | n/a | n/a |
40 | JUND | chr17:19506602-19506712 | HepG2 | liver: | n/a | n/a |
41 | JUND | chr17:19506586-19506785 | HepG2 | liver: | n/a | n/a |
42 | JUND | chr17:19504575-19504678 | HepG2 | liver: | n/a | n/a |
43 | JUND | chr17:19504562-19504694 | HepG2 | liver: | n/a | n/a |
44 | MAFF | chr17:19504944-19504947 | K562 | blood: | n/a | n/a |
45 | MAFF | chr17:19508592-19508754 | K562 | blood: | n/a | n/a |
46 | MAFK | chr17:19508581-19508820 | HepG2 | liver: | n/a | chr17:19508726-19508741 |
47 | MAFK | chr17:19508584-19508798 | IMR90 | lung: | n/a | chr17:19508726-19508741 |
48 | MAFK | chr17:19508568-19508905 | HepG2 | liver: | n/a | chr17:19508726-19508741 |
49 | MYC | chr17:19500365-19500514 | H1-hESC | embryonic stem cell: | n/a | n/a |
50 | MYC | chr17:19498298-19498383 | H1-hESC | embryonic stem cell: | n/a | n/a |
No data |
No data |
(count:7 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-AC115989.1.1-5 | chr17:19507110-19508361 | NONHSAT146507 |
2 | lnc-SLC47A1-1 | chr17:19497523-19497636 | NONHSAT146500 |
3 | lnc-SLC47A1-3 | chr17:19505143-19505569 | NONHSAT146504 |
4 | lnc-SLC47A1-1 | chr17:19499171-19499238 | NONHSAT146500 |
5 | lnc-SLC47A1-1 | chr17:19499326-19499371 | NONHSAT146500 |
6 | lnc-SLC47A2-3 | chr17:19501210-19501235 | ENSG00000262769.1 |
7 | lnc-SLC47A1-3 | chr17:19504173-19504658 | NONHSAT146504 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000224254 | TF binding region |
TRNAQ41P | TF binding region |
ENSG00000262769 | TF binding region |
MTND1P14 | TF binding region |
ENSG00000231625 | TF binding region |
MTND2P12 | TF binding region |
ENSG00000266179 | TF binding region |
ENSG00000271900 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs527363118 | chr17:19494843-19494844 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs547495531 | chr17:19494916-19494917 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs567561347 | chr17:19494929-19494930 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs536283767 | chr17:19494970-19494971 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs555741756 | chr17:19494987-19494988 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs35405907 | chr17:19494989-19494990 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs544453504 | chr17:19495000-19495001 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs569211477 | chr17:19495038-19495039 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs191537338 | chr17:19495039-19495040 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs557945826 | chr17:19495063-19495064 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs138601100 | chr17:19495128-19495129 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs540354490 | chr17:19495151-19495152 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs554280691 | chr17:19495184-19495185 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs573946601 | chr17:19495210-19495211 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs543009822 | chr17:19495253-19495254 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs140648932 | chr17:19495358-19495359 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs531651121 | chr17:19495378-19495379 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs545353780 | chr17:19495400-19495401 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs565060319 | chr17:19495406-19495407 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs111978407 | chr17:19495413-19495414 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs527523767 | chr17:19495421-19495422 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs547174300 | chr17:19495446-19495447 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs561043109 | chr17:19495476-19495477 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs2165895 | chr17:19495478-19495479 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
25 | rs374244523 | chr17:19495607-19495608 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs569180000 | chr17:19495614-19495615 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs145827562 | chr17:19495615-19495616 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs551691778 | chr17:19495646-19495647 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs181307336 | chr17:19495683-19495684 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs372937024 | chr17:19495690-19495691 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs553928501 | chr17:19495736-19495737 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs62065939 | chr17:19495794-19495795 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs574086879 | chr17:19495804-19495805 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs7216938 | chr17:19495926-19495927 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
35 | rs138469243 | chr17:19495938-19495939 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs576543824 | chr17:19495941-19495942 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs373849679 | chr17:19495949-19495950 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs143102062 | chr17:19496008-19496009 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs67870359 | chr17:19496020-19496021 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs572101114 | chr17:19496064-19496065 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs59733667 | chr17:19496092-19496093 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs560788276 | chr17:19496147-19496148 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs529818999 | chr17:19496201-19496202 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs549493579 | chr17:19496232-19496233 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs562929220 | chr17:19496234-19496235 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs530964968 | chr17:19496289-19496290 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs144232892 | chr17:19496292-19496293 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs116793928 | chr17:19496312-19496313 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs546311316 | chr17:19496339-19496340 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs185518520 | chr17:19496364-19496365 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Wilms tumour | 21544195 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Chordoma | 21602918 | CNVD |
Miller-Dieker syndrome | 22283845 | CNVD |
Non-syndromic sensorineural hearing loss | 17457615 | CNVD |
Cancer | 22429812 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Breast cancer | 22028636 | CNVD |
Breast cancer | 20837533 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
colon cancer | 17210682 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Cancer | 16751803 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Chronic lymphocytic leukemia | 17971485 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Breast cancer | 16461572 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Breast cancer | 17133270 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Moyamoya disease | 22323933 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20724749 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Acute myeloid leukemia | 17237825 | CNVD |
Colorectal cancer | 21645411 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
HIV/AIDS | 17953491 | CNVD |
HIV/AIDS | 20877625 | CNVD |
Immune disease | 21076436 | CNVD |
Rheumatoid arthritis | 17953491 | CNVD |
Type 1 diabetes | 17953491 | CNVD |
HIV/AIDS | 15637236 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Neurofibromatosis | 18196300 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Breast cancer | 17001317 | CNVD |
Rhabdomyosarcoma | 16790082 | CNVD |
Charcot-marie-tooth disease | 16463004 | CNVD |
Osteosarcoma | 22292074 | CNVD |
Breast cancer | 17603634 | CNVD |
Charcot | 16760730 | CNVD |
Mental retardation | 17901693 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
ovarian endometriomas | 16273235 | CNVD |
Smith-Magenis syndrome | 18923513 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16272173 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Autism | 22492990 | CNVD |
Congenital abnormalities | 21549014 | CNVD |
Developmental delay | 18414209 | CNVD |
Developmental delay | 21549014 | CNVD |
Epilepsy | 20970697 | CNVD |
Mental retardation | 18414209 | CNVD |
Mental retardation | 21549014 | CNVD |
Smith-Magenis syndrome | 21981782 | CNVD |
Smith-Magenis syndrome | 20188345 | CNVD |
Smith-Magenis syndrome | 16775514 | CNVD |
Smith-Magenis syndrome | 22585170 | CNVD |
Smith-Magenis syndrome | 22241247 | CNVD |
Autism | 20970697 | CNVD |
Mental retardation | 19951919 | CNVD |
Potocki-Lupski syndrome | 21271655 | CNVD |
Potocki-lupski syndrome | 17357070 | CNVD |
Potocki-lupski syndrome | 20110824 | CNVD |
Potocki-lupski syndrome | 18923514 | CNVD |
Potocki-lupski syndrome | 22241247 | CNVD |
Potocki-lupski syndrome | 20188345 | CNVD |
Schizophrenia | 21399695 | CNVD |
Mental retardation | 16773131 | CNVD |
Adenocarcinoma | 19607727 | CNVD |
Squamous cell cancer | 19607727 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Charcot-marie-tooth disease | 22470819 | CNVD |
Neurofibromatosis | 22470819 | CNVD |
Neuropathy | 22470819 | CNVD |
Smith-Magenis syndrome | 18301319 | CNVD |
Smith-Magenis syndrome | 17357070 | CNVD |
Smith-Magenis syndrome | 18469339 | CNVD |
Smith-Magenis syndrome | 22241097 | CNVD |
Smith-Magenis syndrome | 22470819 | CNVD |
Tourette syndrome | 18923514 | CNVD |
Type 1 diabetes | 22470819 | CNVD |
Potocki-lupski syndrome | 18469339 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Neuropathy | 17597781 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 17015230 | CNVD |
Smith-Magenis syndrome | 17597781 | CNVD |
Potocki-lupski syndrome | 18059269 | CNVD |
Potocki-lupski syndrome | 17597781 | CNVD |
Mental retardation | 17847001 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Breast cancer | 20409316 | CNVD |
Autism | 22543975 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Cancer | 20164920 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr17:19493200-19499200 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
2 | chr17:19493400-19499200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr17:19494200-19495000 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
4 | chr17:19494200-19495200 | Enhancers | HepG2 | liver |
5 | chr17:19494400-19495000 | Enhancers | Cortex derived primary cultured neurospheres | brain |
6 | chr17:19494800-19497200 | Weak transcription | Primary monocytes fromperipheralblood | blood |
7 | chr17:19495200-19495600 | Enhancers | Primary mononuclear cells fromperipheralblood | Blood |
8 | chr17:19497200-19498600 | Enhancers | Primary monocytes fromperipheralblood | blood |
9 | chr17:19497400-19497800 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
10 | chr17:19497400-19497800 | Enhancers | Spleen | Spleen |
11 | chr17:19499200-19499400 | Enhancers | Pancreas | Pancrea |
12 | chr17:19499200-19499800 | Strong transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
13 | chr17:19499200-19500400 | Strong transcription | Fetal Adrenal Gland | Adrenal Gland |
14 | chr17:19499400-19505600 | Weak transcription | Pancreas | Pancrea |
15 | chr17:19499800-19519000 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
16 | chr17:19500200-19500400 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
17 | chr17:19500400-19506400 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
18 | chr17:19508000-19508600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
19 | chr17:19508200-19509000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
20 | chr17:19508200-19509000 | Enhancers | A549 | lung |
21 | chr17:19508400-19508600 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
22 | chr17:19509000-19515600 | Weak transcription | A549 | lung |
23 | chr17:19509800-19510000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
24 | chr17:19509800-19511600 | Enhancers | Primary monocytes fromperipheralblood | blood |
25 | chr17:19510000-19511000 | Enhancers | Monocytes-CD14+_RO01746 | blood |
26 | chr17:19511000-19513600 | Weak transcription | Monocytes-CD14+_RO01746 | blood |
27 | chr17:19511600-19513400 | Weak transcription | Primary monocytes fromperipheralblood | blood |
28 | chr17:19513400-19515800 | Enhancers | Primary monocytes fromperipheralblood | blood |
29 | chr17:19513600-19515200 | Enhancers | Monocytes-CD14+_RO01746 | blood |
30 | chr17:19514600-19515200 | Enhancers | Fetal Thymus | thymus |
31 | chr17:19515000-19515800 | Enhancers | GM12878-XiMat | blood |
32 | chr17:19515000-19518200 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |